DEXMEDETOMIDINE AND TRAMADOL FOR MANAGEMENT OF POST-SPINAL ANESTHESIA SHIVERING: A COMPARATIVE STUDY
DOI:
https://doi.org/10.22159/ajpcr.2023v16i10.49364Keywords:
Dexmedetomidine, Tramadol, Post Spinal Anaesthesia Shivering (PSAS), HaemodynamicsAbstract
Objectives: The aim of the study was to compare the efficacy of dexmedetomidine and tramadol in the management of post-spinal anesthesia shivering (PSAS) as well as to compare their side-effect profile.
Methods: This was a comparative study conducted in the department of anaesthesiology in FH Medical College, Etmadpur, Agra. Sixty patients undergoing surgeries under spinal anesthesia were included in this study on the basis of predefined inclusion and exclusion criteria. Patients were given either dexmedetomidine or tramadol depending on the group they belonged to. Efficacy of both the drugs in controlling PSAS, hemodynamic and side effect profile was compared.
Results: The mean age of cases in Group D and Group T was found to be 32.78±8.12 and 35.74±7.92 years, respectively. Mean age and weight as well as gender distribution and American Society of Anesthesiology grades were found to be comparable in both the groups. The mean time for the disappearance of shivering after administration of drug in Group D and Group T was found to be 3.12±1.12 and 5.80±1.20 min, respectively. Meantime for disappearance of shivering was less in Group D as compared to Group T and the difference was found to be statistically “highly significant” (p<0.0001). In Group D, bradycardia was seen in 2 (6.66%) patients whereas hypotension and itching were seen in 1 (3.33%) patient each. In Group T, 6 (20%) patients developed post-operative nausea and vomiting.
Conclusion: Dexmedetomidine is a better alternative to tramadol for the management of PSAS.
Downloads
References
Lopez MB. Postanaesthetic shivering-from pathophysiology to prevention. Rom J Anaesth Intensive Care 2018;25:73-81. doi: 10.21454/rjaic.7518.251
Alfonsi P. Postanaesthetic shivering: Epidemiology, pathophysiology, and approaches to prevention and management. Drugs 2001;61:2193- 205. doi: 10.2165/00003495-200161150-00004
Perez-de-Sá V, Cunha-Goncalves D, Schou H, Jonmarker C, Werner O. The hemodynamic and metabolic effects of shivering during acute normovolemic hemodilution. Anesth Analg 2003;97:972-8. doi: 10.1213/01.ANE.0000081788.79516.CB
Lakhe G, Adhikari KM, Khatri K, Maharjan A, Bajracharya A, Khanal H. Prevention of shivering during spinal anesthesia: Comparison between tramadol, ketamine and ondansetron. JNMA J Nepal Med Assoc 2017;56:395-400. 5. Amsalu H, Zemedkun A, Regasa T, Adamu Y. Evidence-based guideline on prevention and management of shivering after spinal anesthesia in resource-limited settings: Review article. Int J Gen Med 2022;15:6985- 98. doi: 10.2147/IJGM.S370439
Ameta N, Jacob M, Hasnain S, Ramesh G. Comparison of prophylactic use of ketamine, tramadol, and dexmedetomidine for prevention of shivering after spinal anesthesia. J Anaesthesiol Clin Pharmacol 2018;34:352-6. doi: 10.4103/joacp.JOACP_211_16
Naaz S, Ozair E. Dexmedetomidine in current anaesthesia practice-a review [published correction appears in J Clin Diagn Res 2022;16:ZZ01]. J Clin Diagn Res 2014;8:GE01-4. doi: 10.7860/JCDR/2014/9624.4946
Minami K, Ogata J, Uezono Y. What is the main mechanism of tramadol? Naunyn Schmiedebergs Arch Pharmacol 2015;388:999- 1007. doi: 10.1007/s00210-015-1167-5
Rasheed AM, Amirah MF, Abdallah M, Parameaswari PJ, Issa M, Alharthy A. Ramsay sedation scale and richmond agitation sedation scale: A cross-sectional study. Dimens Crit Care Nurs 2019;38:90-5. doi: 10.1097/DCC.0000000000000346
Crossley AW, Mahajan RP. The intensity of postoperative shivering is unrelated to axillary temperature. Anaesthesia 1994;49:205-7. doi: 10.1111/j.1365-2044.1994.tb03422.x
Lewis SR, Nicholson A, Smith AF, Alderson P. Alpha-2 adrenergic agonists for the prevention of shivering following general anaesthesia. Cochrane Database Syst Rev 2015;2015:CD011107. doi: 10.1002/14651858.CD011107.pub2
Subedi M, Bajaj S, Kumar MS, Yc M. An overview of tramadol and its usage in pain management and future perspective. Biomed Pharmacother 2019;111:443-51. doi: 10.1016/j.biopha.2018.12.085
Wang J, Wang Z, Liu J, Wang N. Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: A meta-analysis of randomized controlled trials. BMC Anesthesiol 2020;20:104. doi: 10.1186/s12871-020-01020-y
Kundra TS, Kuthiala G, Shrivastava A, Kaur P. A comparative study on the efficacy of dexmedetomidine and tramadol on post-spinal anesthesia shivering. Saudi J Anaesth 2017;11:2-8. doi: 10.4103/1658- 354X.197344
Zhang SY, Zhao H, Xu C, Zhang Q, Chen Y, Li HY, et al. Combination of dexmedetomidine and tramadol in patient-controlled intravenous analgesia strengthens sedative effect in pregnancy-induced hypertension. Front Pharmacol 2021;12:739749. doi: 10.3389/fphar.2021.739749
Mittal G, Gupta K, Katyal S, Kaushal S. Randomised double-blind comparative study of dexmedetomidine and tramadol for post-spinal anaesthesia shivering. Indian J Anaesth 2014;58:257-62. doi: 10.4103/0019-5049.135031
Liu X, Li Y, Kang L, Wang Q. Recent advances in the clinical value and potential of dexmedetomidine. J Inflamm Res 2021;14:7507-27. doi: 10.2147/JIR.S346089
Begum U, Singh PR, Naithani B, Singh V, Singh GP, Tiwari T. Dexmedetomidine as Bolus or low-dose infusion for the prevention of emergence agitation with sevoflurane anesthesia in pediatric patients. Anesth Essays Res 2019;13:57-62. doi: 10.4103/aer.AER_177_18
Rajan S, Hutcherson MT, Sessler DI, Kurz A, Yang D, Ghobrial M, et al. The effects of dexmedetomidine and remifentanil on hemodynamic stability and analgesic requirement after craniotomy: A randomized controlled trial. J Neurosurg Anesthesiol 2016;28:282-90. doi: 10.1097/ ANA.0000000000000221
Li S, Li P, Lin X. Efficacy of the prophylactic administration of tramadol against postoperative shivering: A meta-analysis of randomized controlled trials. Minerva Anestesiol 2017;83:79-87. doi: 10.23736/ S0375-9393.16.11351-3
Published
How to Cite
Issue
Section
Copyright (c) 2023 ASRA ZIA, SHREYA KUMAR, UMAR SHEIKH, VIVEK BADADA, PRIYA SHARMA
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
